and the Clinical Immunology Section, Veterans Administration, San Francisco, California 94121) NZB/NZW F~ (B/W) 1 mice spontaneously develop an autoimmune disease characterized by lupus erythematosus cell formation, immune complex glomerulonephritis, and production of antibodies to DNA and RNA (1-4). They are considered a laboratory model for human systemic lupus erythematosus. Genetic, immunologic, and viral factors are involved in the pathogenesis of their disease (5). Recent studies implicate a loss of suppressor T cells (6, 7) and a deficiency of thymic hormone (8, 9) as important contributing factors in their disorder.
NZB/NZW F~ (B/W) 1 mice spontaneously develop an autoimmune disease characterized by lupus erythematosus cell formation, immune complex glomerulonephritis, and production of antibodies to DNA and RNA (1) (2) (3) (4) . They are considered a laboratory model for human systemic lupus erythematosus. Genetic, immunologic, and viral factors are involved in the pathogenesis of their disease (5) . Recent studies implicate a loss of suppressor T cells (6, 7) and a deficiency of thymic hormone (8, 9) as important contributing factors in their disorder.
We reported the development of monoclonal macroglobulinemia in one-third of B/W mice over the age of 12 mo (10) . Monoclonal IgM was associated with generalized lymphoproliferation and tumor formation. A malignant lymphoma (141) secreting a monoclonal IgM arose spontaneously in our colony and was established as a transplantable tumor by serial passage into newborn and adult syngeneic recipients. An anti-idiotypic antiserum to the 141 IgM was prepared and used to identify the secreted monoclonal immunoglobulin in the serum of tumor transplant recipients (10) .
Idiotypic determinants on the surface of normal B lymphocytes play an i m p o r t a n t role as receptors for antigens. Anti-idiotypic serum can be sl:ecifically immunosuppressive, suggesting that an i m m u n e response directed against idiotype cell receptors m a y be one mechanism for regulation of the antibody response (11, 12) . Idiotypic determinants on the surface of malignant plasma cells behave like tumor-associated transplantation antigens (13) . Syngeneic mice i m m u n i z e d against the idiotypic determinants on myeloma proteins are specifically protected against the corresponding plasma cell t u m o r which contains the idiotype on its cell surface (14) .
We 
Materials and Methods
Mice. B/W mice were from our colony maintained at the University of California, San Francisco, (17) . 1 ml of control or immune spleen cell suspension (1 x 107 cells) and 0.1 ml of ~Cr-labeled tumor target cell suspension (5 x 10' cells), was pipetted into 35 x 10-mm plastic petri dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). The immune cell to target cell ratio was 200:1. Cultures were performed with 2-3 replicates. Dishes were placed in horizontal trays on a rocking platform at 37°C in a moist atmosphere of 90% air and 10% carbon dioxide. Dishes were rocked continuously at 6 complete cycles/min during the incubation period of 7 or 15 h. After incubation, the contents of each petri dish were transferred into tubes with 1 ml of cold medium and centrifuged at 400 g for 10 min. 1 ml of supernate from each tube was assayed for radioactivity (5~Cr release) in a Packard ~-Scintillation counter (Packard Instrument Co., Inc., Downers Grove, Ill.). The specific cytotoxicity was then calculated as follows:
E, cpm of ~Cr released from cells in the petri dish containing experimental ceils; C, cpm of 51Cr released from cells in the petri dish containing normal cells; and T, cpm of 5~Cr released from cells in the petri dish containing 1 ml of distilled water. Inhibition of cell-mediated cytotoxicity by 141 IgM or 104E IgM was performed by incubating 1.0 ml of spleen cells (4 x 10Vml) with 1.0 ml of 141 IgM or 104E IgM (100 #g/ml or 160 ttg/ml) for 30 min at 37°C. After incubation, cells were washed and adjusted to 1 x 10Vml viable cells in RPMI 1640 medium.
Assay for Complement-Dependent Cytotoxicity. Complement-dependent humoral cytotoxicity
was determined by mixing 0.1 ml of 51Cr-labeled target cells with 0.1 ml of antl-idiotypic serum and 0.1 ml of five times diluted rabbit serum preabsorbed with lymphoma 141 cells. The percent cytotoxicity was calculated the same way as for cell-mediated cytotoxicity.
Lymphocyte Transformation by 141 IgM or I04E IgM. Spleen cells from B/W mice preimmu-
nized with IgM 141 and challenged with the corresponding 141 lymphoma were either pretreated with 141 or 104E IgM before washing and culturing, or cultured in the presence of IgM (5-100 ttg/ml). The proteins were first dialyzed against RPMI 1640. Spleen cells from control B/W mice who were neither immunized nor challenged with tumor were handled in the same way. Cultures of 5.0 x 105 lymphocytes in a final vol of 0.2 ml were established in microtiter plates, using RPMI 1640 medium containing 10 mM Hepes buffer and 1% antibiotic-antimycotic mixture (GIBCO). They were maintained in 5% CO~ at 37°C. 1 ttCi of tritiated thymidine (3,000 mCi/mM) was added 8-12 h before automated suction harvesting with saline, trichloracetic acid, and methonol on the 4th day (18) . Data shown are mean ± standard errors of counts per minute incorporated, usually from three or four replicate cultures. The difference between 141 IgM-stimulated incorporation and 104E IgMstimulated incorporation in control spleen cells was compared with the corresponding difference in protected spleen cells using the Student's t test. Statistical significance was determined from the means and standard errors of the logarithms of the incorporated radioactivity, pooling the variance of the logarithms.
Antibody Activity of 141 IgM. 
Results
Idiotypic Determinants on Cell Surface Membranes. The presence of idiotypic determinants on the surface of lymphoma 141 cells was demonstrated by indirect immunofluorescence using rabbit anti-idiotypic antiserum (Fig. 1) .The in-tensity of fluorescence diminished with dilution of the anti-idiotype serum, but some staining was still seen even at 1:1,280 dilution (Table I) . To confirm the specificity of this staining reaction, inhibition studies were performed using purified monoclonal IgM from lymphoma 141 and from a BALB/c plasmacytoma (MOPC 104E). The 141 IgM inhibited the fluorescent staining completely, whereas the 104E IgM had no effect (Table I) . Two further specificity controls were performed: (a) anti-idiotypic serum prepared against another B/W monoclonal IgM (108) failed to show immunofluorescence against the lymphoma 141 cells, and (b) anti-idiotypic serum against lymphoma 141 failed to show membrane immunofluorescence against another B/W transplantable lymphoma (10) maintained in our laboratory. Lymphoma 10 does have surface immunoglobulin since it shows membrane immunofluorescence with antiserum against ~-heavy chain and K-light chain. We attempted to induce "capping" by exposure of lymphoma 141 cells to anti-idiotypic antiserum followed by incubation at 37 °C for various time periods. Only about 10% of cells showed typical "capping" after 3-h incubation; the majority of cells showed membrane localization in a crescent pattern over approximately 30% of the cell surface (Fig. 1) . There was no increase in typical capping even when a double antibody method was used (incubation with rabbit anti-idiotype and goat antirabbit sera at 37°C for up to 12 h). Additional evidence for the presence of idiotypic determinants on lymphoma 141 cells was provided by cytotoxicity studies using tumor cells labeled with radioactive chromium. The rabbit anti-idiotypic serum was highly cytotoxic in the presence of complement. As with the immunofluorescent studies, this cytotoxicity was specifically inhibited by 141 IgM but not by 104E IgM (Table I) . These inhibition studies confirm the specificity of the anti-idiotypic serum against cell surface immunoglobulins and indicate the accessibility of the idiotypic determinants on the cell membrane.
Protection Against Lymphoma 141 by Prior Immunization with 141 IgM. Experiments by Lynch and colleagues suggest that idiotypic determinants on induced BALB/c plasma cell tumors behave as tumor-associated transplantation antigens (13) . We studied whether the idiotype of 141, a naturally occurring BfW lymphoma, could function in the same way. In the first experiment, 6-mo old B/W male mice were immunized with either 141 IgM or human macroglobulinemic serum in complete Freund's adjuvant. After the third injection, the immunized mice received 1.5 × 107 lymphoma 141 cells injected subcutaneously. Tumor nodules appeared in all mice 15 days later and grew progressively. Three out of five mice immunized with 141 IgM showed tumor regression starting about day 35 (Fig. 2) . One regressor mouse was sacrificed for cytotoxicity studies (see (Fig. 2) . Four out of five mice immunized with 141 IgM had only a small tumor nodule on the 35th day.
Because of the close similarity between 141 IgM and 104E IgM, it is of interest to compare the survival data of mice immunized with these monoclonal mouse macroglobulins. All seven mice immunized with 141 IgM survived past day 35 after tumor grafting, whereas all five mice immunized with 104E IgM died before day 28. These results are highly significant (p < 0.001) by chi square analysis with Yates modification.
Mechanism of Protection against Lymphoma 141. Sera from mice regressing tumors were studied for cytotoxic activity against lymphoma 141 cells labeled with radioactive chromium. Whereas rabbit anti-idiotypic antiserum was highly cytotoxic (Table I) , regressor sera killed only 7-20% of the tumor cells (compared to control sera from mice with progressive tumors which killed 1-5% of tumor cells). These results suggest that humoral immunity against lymphoma 141 was present but rather weak. We could not detect any antibody-dependent cellular cytotoxicity using regressor sera and normal mouse spleen cells.
By contrast, cellular cytotoxicity against lymphoma 141 was observed in four out of five protected mice studied (Table II) . The degree of positive cytotoxicity varied from 26-88%. The specificity of this cytotoxic activity was studied. In two experiments (mice 536 and 537), spleen cells were cytotoxic against lymphoma 141 but not against lymphoma 10. Moreover, in mice 501 and 536, cytotoxicity by spleen cells could be specifically blocked by prior incubation with 141 IgM but not with 104E IgM (Table II) . These results suggest the presence in protected or regressor mice of spleen cells specifically cytotoxic for lymphoma 141, presumably by virtue of idiotypic recognition.
The presence of such spleen cells capable of recognizing idiotype was detected by a second assay procedure. Spleen cells from protected mice were exposed to 141 or 104E IgM in tissue culture and the incorporation of [3H]thymidine into DNA was measured. Responses were compared with control B/W mice. In general, neither protein stimulated DNA synthesis in control spleen cells, whereas 141 IgM but not 104E IgM stimulated DNA synthesis in cells from experimental mice (Table III) . In the first experiment, the specific proliferative response to 141 IgM was partially dependent upon the concentration of IgM used to stimulate the cells. In the second experiment, a specific response was obtained by leaving the IgM in the cultures but not by removing it before culturing. In the third experiment, metastases to the spleen reduced baseline synthesis 10-fold, but responsiveness specific for 141 IgM was still evident. Thus, in all three experiments, there was stimulation of spleen cells from protected mice by 141 IBM but not by 104E IgM.
Lack of Detectable Antibody Activity in 141
IgM. About 5% of monoclonal immunoglobulins have been shown to combine with specific antigens (15, 22) . MOPC 104E, for example, reacts with al -* 3 dextrans (15). Many monoclonal IgMs in humans are antigamma globulins and have rheumatoid factor-like properties (22, 23) . We have tried to find an antibody activit:¢ for the 141 IgM that arose spontaneously in B/W mice. We are unable to detect activity against DNA or RNA, mouse gamma globulin, mouse erythrocytes, mouse thymocytes, al -~ 3 dextran, or mouse leukemia viral antigens.
Discussion
This study demonstrates the presence and potential significance of idiotypic determinants on the surface membranes of an IgM-producing lymphoma (141) that arose spontaneously in B/W mice. The presence of idiotype was shown by immunofluorescence and cytotoxicity using a rabbit anti-idiotypic antiserum. The specificity was confirmed by inhibition with 141 IgM but not with 104E IgM, a monoclonal IgM produced by an oil-induced plasmacytoma of BALB/c origin. Moreover, another B/W lymphoma (10) failed to show membrane fluorescence with anti-idiotypic serum directed against 141.
Surface membrane immunoglobulins are a distinguishing characteristic of normal and malignant B lymphocytes. In normal human peripheral blood, about 25% of circulating lymphocytes show surface immunoglobulin by immunofluorescenee with polyvalent antiserum (24) . In chronic lymphocytic leukemia, almost 100% of circulating lymphocytes show membrane immunoglobulin and are classified as B lymphocytes. This membrane immunoglobulin is often monoclonal, belonging to either the IgG or IgM immunoglobulin class (25) , In Waldenstrom's macroglobulinemia, the majority of circulating lymphocytes contain the monoclonal IgM on their cell surface (25) . Indeed, in Waldenstrom's macroglobulinemia and cold agglutinin disease, the secreted monoclonal IgM and the cell surface IgM have the same idiotype as shown by cytotoxicity (26) . This result indicates that the same unique antigenic determinants are present both on the secreted immunoglobulin and on the cell surface immunoglobulin.
The potential significance of finding idiotypic determinants on the surface membranes is shown by their ability to function as tumor-associated transplantation antigens. Our experiments relate to the work of Eisen and associates who first observed that BALB/c mice produced "autoimmune-like" antibodies against unique idiotypic determinants present in the ligand-combining sites of some functional BALB/c myeloma proteins (27) . They next observed (13) that such immunized mice could specifically suppress growth of the corresponding transplanted tumor cells (either MOPC-315 or MOPC-460). In all, they found anti-idiotypic antibody responses in BALB/c mice to 6 of 7 myeloma proteins, and in three cases, animals making an anti-idiotypic response suppress growth of the corresponding plasmacytoma (H. N. Eisen, personal communication). They did not look for cell-mediated immunity in their protected mice, but considered cellular immunity directed against idiotypic determinants as a possibility.
Our experiments with a natural tumor of B/W mice extend Eisen's observations. Our results strongly suggest that cellular immunity directed against idiotype is present in the spleens of regressor and protected mice. Both by cytotoxicity and lymphocyte stimulation, evidence was obtained for cellular sensitization to the syngeneic 141 IgM. Four out of five cytotoxicity experiments were positive, and in each of two experiments, cellular cytotoxicity was inhibited by 141 IgM but not by 104E IgM. Likewise, splenic lymphocytes from protected mice were stimulated to synthesize DNA by 141 IgM but not by 104E IgM. Thus, this phenomenon appears to represent cellular "autoimmunity" directed against idiotype, the counterpart of Eisen's finding with humoral immunity.
Recognition of antigenic determinants on 141 IgM that are not idiotypic are largely excluded by using the 104E IgM as a control. The lack of another BAV monoclonal IgM prevents further specificity controls at this time. However, since idiotypic determinants are known to function as tumor-associated transplantation antigens conferring protective immunity (13) , and since idiotypic determinants are accessible on the surface membranes of lymphoma 141 cells, we interpret our results to suggest cellular recognition of idiotype as the most likely protective mechanism.
Our failure to detect much humoral immunity against idiotype in the protected mice may be due to lack of an assay such as Eisen employed that measures the interaction between monoclonal antibody, anti-idiotype, and specific ligand (27) . Such an assay depends upon a known functional activity for the monoclonal protein, which we have been unable to find.
The nature of the cytotoxic cell will be studied in future experiments. We presume it to be a T lymphocyte. Rollinghoff and Wagner have recently shown that T cells are required for both the induction of immunity and the effector phase of cell-mediated cytotoxicity directed against plasmacytomas (28) . Furthermore, allotype suppression requiring the active presence of T lymphocytes has been reported (29) .
The presence of lymphocytes with receptors capable of recognizing idiotype may also have important implications for immune regulation. Anti-idiotypic serum can be specifically immunosuppressive. For example, anti-idiotypic serum directed against receptors for phosphorylcholine can suppress a normal immune response to phosphorylcholine (11) . A theory of regulation based on antireceptor (idiotype) recognition has been proposed as a means for limiting the extent of an immune response (12, 30) . Our findings suggest that cellular as well as humoral mechanisms may participate in such regulation. Indeed, lymphocytes capable of recognizing idiotype receptors on other lymphocytes could function as suppressor cells by releasing cytotoxic or inhibitory factors. If the receptors were those capable of binding autoantigens, such a suppressor mechanism could function normally to prevent the proliferation of autoantibody producing clones and the release of autoantibodies. The lack of such a regulatory mechanism might contribute to some types of autoimmune and lymphoproliferative disorders. Moreover, the generation of lymphocytes capable of recognizing idiotype receptors for autoantigens might have therapeutic potential in these diseases. Since functional monoclonal proteins exist in mice (15) , this possibility can be tcsted experimentally. Received for publication 18 July 1974. 
